GENE ONLINE|News &
Opinion
Blog

FDA
In-Depth
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
Trials & Approvals
Multifaceted Farxiga Shows Benefit in Chronic Kidney Disease
2020-07-30
Trials & Approvals CAR T-cell Therapy
First and Only CAR T Therapy for Mantle Cell Lymphoma Gets FDA Nod
2020-07-30
Part II Highlights of BIO Asia-Taiwan 2020 (Day 1): Global Trends in Biotech and the Impact of COVID-19
2020-07-23Partner
COVID-19
Regeneron Secures $4.5 Billion Worth of Contracts from the US for Combating COVID-19
2020-07-10
Trials & Approvals Novartis
Novartis Wins Five Simultaneous Drug Approvals in Japan
2020-07-06
Trials & Approvals Bladder Cancer
Bavencio Bags FDA Approval as First-line Maintenance Treatment for Urothelial Carcinoma
2020-07-05
Trials & Approvals
Spotlight: Roche’s SMA Drug, Risdiplam Makes Strong Case for Regulatory Approval
2020-07-05
Trials & Approvals Cancer
FDA Approves Crysvita for Victims of Tumor-Induced Osteomalacia
2020-07-03
Trials & Approvals
With NASH Drug Rejected, Intercept CEO Lambasts FDA’s Evolving Guidelines
2020-07-01
Clostridium Difficile
Finch’s First Microbial Cocktail Treating Clostridium Infection Registers Positive Results
2020-06-24
BIO Digital 2020 Highlights: Challenges in Bringing New Cell and Gene Therapies to Market
2020-06-23
COVID-19
BIO Digital 2020 Highlights: Leveraging Platforms and Partnerships to Develop COVID-19 Vaccines in Record Time
2020-06-21
COVID-19
FDA Revokes Emergency Authorization of Malarial Drugs for Treating COVID-19
2020-06-18
Trials & Approvals Pneumonia
FDA Okays Merck ‘s Combination Antibiotic for Hospital-Acquired Bacterial Pneumonia
2020-06-12
1 … 17 18 19 20 21 … 24
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top